A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer
Clinical trial NCT02024607 · COMPLETED
Trial details
- NCT number
- NCT02024607
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2019-03-01
- Enrollment
- 495
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.